InvestorsHub Logo
Followers 144
Posts 27603
Boards Moderated 3
Alias Born 02/07/2004

Re: None

Thursday, 06/10/2021 1:52:17 PM

Thursday, June 10, 2021 1:52:17 PM

Post# of 3894
RedHill Biopharma confident about Covid 19 oral pill progress

https://www.proactiveinvestors.com/companies/news/951966/redhill-biopharma-confident-about-covid-19-oral-pill-progress-951966.html

Newsflow relating to Covid 19 vaccinations is plentiful, but what of potential treatments in the form of oral medication?

Nasdaq-listed RedHill Biopharma (NASDAQ:RDHL) is involved in that search. As chief business officer Guy Goldberg explains to Proactive London's Sarah Lowther the company is confident it may soon have a new weapon in the fight against the pandemic.

The biopharmaceutical company has completed the enrollment of its oral Opaganib phase 2/3 COVID-19 Study. The primary endpoint of the study, says RedHill, is the proportion of patients breathing room air without oxygen support by Day 14.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News